follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Aerie Pharmaceuticals files IPO registration

By

Back to Top Comments Email Print

News You Can Use

Latest News

advertisement

Bedminster-based Aerie Pharmaceuticals Inc. announced Monday it has registered with the Securities and Exchange Commission for an initial public offering. The offering will consist of common stock.

According to the announcement, the number of shares to be offered and the price range for the offering have not been determined. RBC Capital Markets and Stifel will serve as joint book-running managers for the offering. Lazard Capital Markets and Canaccord Genuity will serve as co-managers.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top